I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 19% ± 5% | |
| glutamatergic neuron | 3 studies | 31% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 19% ± 5% | |
| glutamatergic neuron | 3 studies | 31% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 5036.71 | 245 / 245 | 100% | 112.21 | 502 / 502 |
| brain | 100% | 991.19 | 2636 / 2642 | 100% | 5.68 | 703 / 705 |
| esophagus | 100% | 948.75 | 1445 / 1445 | 99% | 5.85 | 181 / 183 |
| kidney | 100% | 538.44 | 89 / 89 | 99% | 5.20 | 888 / 901 |
| breast | 100% | 665.62 | 459 / 459 | 98% | 5.30 | 1098 / 1118 |
| thymus | 100% | 885.86 | 653 / 653 | 98% | 4.70 | 590 / 605 |
| lung | 100% | 592.34 | 576 / 578 | 96% | 3.69 | 1110 / 1155 |
| intestine | 100% | 1090.72 | 966 / 966 | 95% | 3.25 | 502 / 527 |
| uterus | 100% | 901.32 | 170 / 170 | 94% | 3.61 | 433 / 459 |
| adrenal gland | 99% | 480.13 | 255 / 258 | 95% | 4.98 | 219 / 230 |
| ovary | 100% | 689.72 | 180 / 180 | 93% | 2.27 | 398 / 430 |
| stomach | 98% | 457.95 | 351 / 359 | 93% | 3.78 | 267 / 286 |
| skin | 100% | 636.69 | 1806 / 1809 | 91% | 4.36 | 429 / 472 |
| bladder | 100% | 669.33 | 21 / 21 | 77% | 2.71 | 386 / 504 |
| pancreas | 80% | 191.72 | 264 / 328 | 96% | 3.63 | 171 / 178 |
| liver | 90% | 244.65 | 203 / 226 | 52% | 1.32 | 212 / 406 |
| adipose | 100% | 785.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 595.98 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 684.25 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 3.34 | 43 / 45 |
| heart | 95% | 334.36 | 814 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 10.46 | 20 / 29 |
| muscle | 67% | 148.87 | 541 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 43% | 0.82 | 34 / 80 |
| peripheral blood | 17% | 42.30 | 162 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0140882 | Biological process | zinc export across plasma membrane |
| GO_0009636 | Biological process | response to toxic substance |
| GO_0140916 | Biological process | zinc ion import into lysosome |
| GO_0071577 | Biological process | zinc ion transmembrane transport |
| GO_0010043 | Biological process | response to zinc ion |
| GO_0010008 | Cellular component | endosome membrane |
| GO_0031902 | Cellular component | late endosome membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0005770 | Cellular component | late endosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005385 | Molecular function | zinc ion transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | SLC30A4 |
| Protein name | Probable proton-coupled zinc antiporter SLC30A4 (Solute carrier family 30 member 4) (Zinc transporter 4) (ZnT-4) |
| Synonyms | ZNT4 |
| Description | FUNCTION: Probable proton-coupled zinc ion antiporter mediating zinc import from cytoplasm potentially into the endocytic compartment . Controls zinc deposition in milk (By similarity). . |
| Accessions | O14863 ENST00000261867.5 |
